About Scale Biosciences
Scale Biosciences strives to unlock complex biology by enabling single-cell analysis with our patented combinatorial indexing technology.
We are developing products that enable unprecedented scale at a fraction of the cost, allowing researchers to ask new questions in single-cell research.
Our goal is to transform single-cell analysis and to pave the way for new and ground-breaking discoveries in single-cell biology.
ScaleBio has a world-class founding team and well-respected Board and Investor syndicate that brings a proven track record in building game changing life sciences tools companies.
Scalebio’s mission is to enable researchers across a broad range of fields of study and single-cell applications to unlock the potential of single-cell sequencing at scale and discover complex biology at single-cell resolution.
We believe single cell analysis will power the next generation of biomedical research breakthroughs and every lab should be able to access it.
Scalable cell throughout
Scalable sample indexing
Highly efficient chemistries
Low library preparation costs
Join our team
Check out our available postings.
Nov 02, 2023
Scale Biosciences Announces Presentations at Upcoming Scientific Conferences
Scale Biosciences announces upcoming customer presentations and upcoming product data releases at ASHG and SfN, both being held in Washington, D.C.
Aug 29, 2023
Scale Biosciences Continues Commercial Expansion with Introduction of New and Differentiated Single Cell Methylation and Single Cell RNA Sequencing Solutions
Scale Biosciences announces new and differentiated single cell methylation and single cell RNA sequencing solutions.